Targeting insulin-like growth factor axis in hepatocellular carcinoma
<p>Abstract</p> <p>The insulin-like growth factor (IGF) axis contains ligands, receptors, substrates, and ligand binding proteins. The essential role of IGF axis in hepatocellular carcinoma (HCC) has been illustrated in HCC cell lines and in animal xenograft models. Preclinical evi...
Main Authors: | Wu Jennifer, Zhu Andrew X |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/4/1/30 |
Similar Items
-
Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway.
by: Da-Liang Ou, et al.
Published: (2013-01-01) -
The expression of insulin-like growth factor II gene in human hepatocellular carcinoma
by: HUANG, hsiang-po, et al.
Published: (1994) -
Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese Women
by: Zhu Y, et al.
Published: (2020-08-01) -
Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
by: Akiel M, et al.
Published: (2014-03-01) -
Association of polymorphism of insulin-like growth factor genes with susceptibility to and severity of hepatocellular carcinoma
by: Yin-Hung, et al.
Published: (2009)